Host genes play an important role in the pathogenesis of influenza virus infection.
High-throughput technologies accelerate the discovery of susceptibility genes.
Host susceptibility studies facilitate the development of host-targeted therapy.
Host-targeted therapy may allow individualized treatment for influenza.